Bionova Scientific struck a manufacturing alliance with genetic delivery company Syenex to expand global access to plasmid DNA for viral and mRNA production; the partnership will make Bionova a preferred plasmid supplier for Syenex platforms and broaden off‑the‑shelf plasmid offerings. Coverage: GEN. Aragen Biologics launched CHOMax, a cell line development and early manufacturing platform that claims an integrated DNA‑to‑IND path for standard IgG monoclonal antibodies, emphasizing speed and regulatory-aligned workflows. Both announcements reflect CDMOs extending platform services to shorten timelines to IND. Companies developing gene and biologic therapies will weigh these supply-chain options as they plan CMC packages and scale-up strategies ahead of clinical-readout milestones.